α1 and α2-adrenoceptors in the medial amygdaloid nucleus modulate differently the cardiovascular responses to restraint stress in rats  by Fortaleza, Eduardo Albino Trindade et al.
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Medial  amygdaloid  nucleus  (MeA)  neurotransmission  has  an  inhibitory  inﬂuence  on  cardiovascular
responses  in  rats  submitted  to restraint,  which  are  characterized  by both  elevated  blood  pressure  (BP)  and
intense  heart  rate  (HR)  increase.  In the  present  study,  we  investigated  the  involvement  of  MeA  adreno-
ceptors  in  the  modulation  of  cardiovascular  responses  that  are  observed  during  an  acute  restraint.  Male
Wistar rats  received  bilateral  microinjections  of  the  selective  1-adrenoceptor  antagonist  WB4101  (10,
15, and  20  nmol/100  nL)  or the  selective  2-adrenoceptor  antagonist  RX821002  (10,  15,  and  20 nmol/nL)drenoceptors
ardiovascular system
estraint stress
utonomic nervous system
into  the  MeA,  before  the  exposure  to  acute  restraint.  The  injection  of WB4101  reduced  the restraint-
evoked  tachycardia.  In  contrast,  the  injection  of  RX821002  increased  the  tachycardia.  Both  drugs  had
no inﬂuence  on  BP  increases  observed  during  the  acute  restraint.  Our  ﬁndings  indicate  that  1  and  2-
adrenoceptors  in the  MeA  play  different  roles  in  the  modulation  of  the HR  increase  evoked  by  restraint
stress  in  rats.  Results  suggest  that  1-adrenoceptors  and  2-adrenoceptors  mediate  the  MeA-related
facilitatory  and inhibitory  inﬂuences  on restraint-related  HR  responses,  respectively.. Introduction
Stress elicits both autonomic and behavioral responses, which
nvolve an activation of the hypothalamo-pituitary–adrenal axis
s well as the sympathetic nervous system [1].  Such responses
re modulated by several limbic structures in the central nervous
ystem [2–7]. Among these structures, the amygdaloid complex
s known to modulate stress-related behavior and is connected
ith hypothalamic and brainstem areas that are involved with
ardiovascular regulation [8–10]. In particular, the medial amyg-
aloid nucleus (MeA) of the amygdaloid complex is involved
n the modulation of stress related responses and in cardio-
ascular control [1,11].  Electrical stimulation of the MeA  was
eported to evoke increased blood pressure and heart rate
12].Stress is known to evoke cardiovascular changes that are
haracterized by moderate hypertension and intense tachy-
ardia [4,7,13–20].  Pressor responses evoked by foot-shock in
Abbreviations: aCSF, artiﬁcial cerebrospinal ﬂuid; ANOVA, analysis of variance;
P,  blood pressure; HR, heart rate; MAP, mean arterial pressure; MeA, medial amyg-
aloid nucleus; PAP, pulsatile arterial pressure; RS, restraint stress.
∗ Corresponding author at: Department of Pharmacology, School of Medicine of
ibeirão Preto, USP, Bandeirantes Avenue, 3900, 14049-900 Ribeirão Preto, São
aulo, Brazil. Tel.: +55 16 3602 3206; fax: +55 16 3633 2301.
E-mail address: fmdacorr@fmrp.usp.br (F.M. de Aguiar Corrêa).
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Open access under the Elsevier OA license.© 2012 Elsevier Ltd. 
spontaneously hypertensive rats increased blood pressure and
heart rate with contextual fear conditioning [6,21],  while with
exposure of borderline hypertensive rats to acute noise stress [22]
they were reduced after electrolytic lesion of the amygdala, thus
suggesting an involvement of the amygdala in the modulation of
cardiovascular responses caused by stress. Moreover, increased c-
fos expression in the MeA  was observed after exposure to a number
of stressors, such as a novel environment, swimming, social inter-
action and acute restraint stress [23,24].
MeA  inhibition with muscimol was reported to attenuate
the pressor response evoked during acute restraint [19]. Also,
previous work from our laboratory showed that bilateral microin-
jection of the unspeciﬁc neurotransmitter blocker Cobalt chloride
(CoCl2) into the MeA  caused enhanced restraint-related tachycar-
diac response [4].  These data suggest the involvement of this area
in cardiovascular modulation during stress.
The MeA  receives substantial noradrenergic innervations orig-
inating in the A6 neurons in the locus coeruleus (LC) and other
groups of noradrenergic neurons located in the lateral tegmental
area [25,26].  Furthermore, studies of expression of mRNA and bind-
ing detected the presence of noradrenergic receptor subtypes  and
 in the MeA  [27,28], suggesting the existence of the noradrenergic
system in this area.
Open access under the Elsevier OA license.Noradrenaline (NA) is a neurotransmitter with an important role
in central cardiovascular regulation and is an important mediator
in several structures of the central nervous system. Cardiovascu-
lar responses were observed after microinjection of NA into brain
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egions involved in the modulation of the cardiovascular system,
uch as the nucleus of the solitary tract (NTS); [29], the medial pre-
rontal cortex (CPFM); [30], the periaqueductal gray area (PAG);
31], the lateral septal area (ASL); [32], the bed nucleus of the stria
erminal (BST); [33], the supraoptic nucleus (SON); [34] and the
eA  [35].
Studies using microdialysis have shown increased levels of NA in
everal forebrain regions of the limbic system, mainly in the MeA
f animals subjected to stress situations [1,36–40]. Although the
oradrenergic system activation occurs in the MeA  during stress,
he role of this activation in the mediation of stress-induced car-
iovascular responses has not yet been evaluated.
Several studies in the literature support the idea that acute
estraint is an unavoidable aversive stimulus eliciting sustained
P and HR increase [41–46].  In this way, in the present study, we
ested the hypothesis that noradrenergic neurotransmission within
he MeA  mediates the cardiovascular responses evoked by restraint
tress. For that purpose, we pretreated the MeA  with adrenoceptor
ntagonists and submitted the rats to acute restraint, after which
e observed the cardiovascular responses evoked by this stressor.
. Materials and methods
.1. Subjects
Experimental procedures were carried out following proto-
ols approved by the Ethical Review Committee of the School of
edicine of Ribeirão Preto (no. 057/2009). Male Wistar rats weigh-
ng 250–280 g were used in the present experiment. Animals were
oused individually in plastic cages in a temperature-controlled
oom (25 ◦C) at the Animal Care Unit of the Department of Phar-
acology, School of Medicine of Ribeirão Preto. Animals were
ept under a 12:12 h light–dark cycle (lights on at 06:00). Ani-
als had free access to water and standard laboratory food, except
uring the experimental period. Rats were transported to the
xperiment room and remained in their own cages until the exper-
mental restraint procedure. Experiments were performed during
he morning period to minimize possible circadian rhythm inter-
erences.
.2. Surgical preparation
Animals were anesthetized with tribromoethanol (250 mg/kg
.p.) and their heads were ﬁxed to a stereotaxic apparatus (Stoelting,
SA). The skull was surgically exposed and trepanned with a dental
rill at a point located 3.4 mm  from midline and 6.2 mm anterior to
he interaural line, according to the rat brain atlas of Paxinos and
atson [47]. Bilateral stainless steel guide cannulae (26G, 15 mm-
ong) were lowered 8.0 mm from the skull. Guide cannulae were
ositioned 1 mm  above the intended injection sites and ﬁxed to the
kull by a metal screw and dental cement. Animals were allowed
o recover for 48 h before a polyethylene catheter was implanted
nto the femoral artery under anesthesia, for chronic recording of
rterial BP and HR. The catheter was exposed on the dorsum of
he animals and attached to the skin, allowing arterial pressure
ecording of unanesthetized rats 24 h after surgery.
.3. Drug microinjection into the MeA
Injections were performed in a volume of 100 nL. For microinjec-
ions, we used a 1 L syringe (KH7001, Hamilton, USA) connected to
 33G injection needle (Small Parts Inc, FL, USA) by PE-10 polyethy-
ene tubing. The injection needle was 1.0 mm longer than the guide
annula.al Research 66 (2012) 154– 162 155
2.4. Measurement of cardiovascular responses
Pulsatile arterial pressure (PAP) was  recorded using an ampliﬁer
(model 7754A, Hewlett Packard, USA) coupled to a computerized
acquisition system (MP100, Biopac, USA). Mean arterial pressure
(MAP) and HR were derived from PAP data using the AcqKnowl-
edge III Software (Biopac, USA). The MAP  was  calculated according
to the equation: diastolic pressure + (systolic–diastolic)/3. The HR
(beats/min; bpm) was  calculated from PAP peak intervals that were
integrated each 6 s.
2.5. Drugs utilized in the experimental procedures
The following drugs were used: Vehicle artiﬁcial cerebrospinal
ﬂuid (ACSF) had the following composition: 100 mM NaCl; 2 mM
Na 3 PO 4; 2.5 mM KCl; 1 mM MgCl 2; 27 mM NaHCO 3; 2.5 mM
CaCl 2 and pH = 7.4), RX821002 (2-adrenoceptor antagonist),
WB4101 (1-adrenoceptor antagonist) urethane (Sigma, USA),
tribromoethanol (Aldrich, USA), streptomycins and penicillins
(Pentabiotico, Fort Dodge, Brazil), ﬂunixine meglumine (Banamine,
Schering Plough, Brazil).
2.6. Experimental procedure: acute restraint
Animals were transported to the experimental room in their
home cages. They were allowed a 1 h period to adapt to the
conditions of the experimental room, such as sound and illumi-
nation, before starting blood pressure and heart rate recording.
The experimental room was acoustically isolated and had a con-
stant background noise generated by an air exhauster. At least
another 20 min  period was allowed for baseline recording before
experiments were initiated. After recording baseline values, bilat-
eral microinjections of drugs or vehicle were made into the MeA,
each animal receiving only one microinjection per brain side. Care
was  taken to start injection whenever a stable blood pressure and
especially a stable heart rate recording were observed. The injection
needle was slowly introduced through the guide cannula without
touching or restraining the animals. Ten min  later, the animals were
submitted to restraint, which was initiated by putting animals into
a small plastic cylindrical restraining tube (diameter = 6.5 cm and
length = 15 cm). Restraint lasted for 60 min  and immediately after,
the animals were returned to their cages. Each animal was submit-
ted to one session of restraint in order to prevent habituation.
Animals were divided into seven experimental groups: (1)
aCSF group, vehicle microinjected into the MeA, (2) WB4101 dose
10 nmol group, (3) WB4101 dose 15 nmol group, (4) WB4101 dose
20 nmol group, (5) RX821002 dose 10 nmol group, (6) RX821002
dose 15 nmol group and (7) RX821002 dose 20 nmol group. The
vehicle and all drugs were microinjected bilaterally into the
MeA.
2.7. Histological determination of the microinjection sites
At the end of the experiments, animals were anesthetized with
urethane (1.25 g/kg i.p.) and 100 nL of 1% Evan’s blue was injected
into the brain as a marker at the injection site. Animals were
submitted to intracardiac perfusion with 0.9% NaCl followed by
10% formalin. Brains were removed, and post-ﬁxed for 48 h at
4 ◦C and serial 40 m-thick sections were cut with a cryostat
(CM1900, Leica, Germany). Sections were stained with 1% violet
cresyl for optical microscopy analysis. The actual placement of the
microinjection needles was determined by analyzing serial sec-
tions, according to the rat brain atlas of Paxinos and Watson [47].
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Fig. 1. (A) Diagrammatic representation modiﬁed from the rat brain atlas of Paxinos and Watson [47] indicating microinjection sites in the brain of rats used in the present
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f  a coronal section of a representative rat brain showing the sites of bilateral microi
f  the amygdala; BLA – basolateral nucleus of the amygdala; OT – optic tract.
.8. Statistical analysis
Statistical analysis was performed using Prism software (Graph-
ad, USA). The paired Student’s t-test was used to compare basal
AP  and HR values before and after aCSF or drug treatment.
o determine and compared MAP  and HR changes, we used
ne-way ANOVA followed by Dunnett’s test, to verify alterations
etween aCSF and drug treatments.
Although blood pressure was recorded throughout the exper-
mental procedure, curves for statistical analysis or illustrative
gures were generated with points obtained from different
ata sampling. Figs. 3 and 4 were generated from samplings
f 0.64/min for more accurate representation. To verify possi-
le correlations between drug doses and MAP  or HR values,
e used linear regression curves that were generated from
elected points recorded during the 60 min  restraint stress period.
he signiﬁcance was set at p < 0.05. Data are presented as
ean ± SEM.de), WB4101 (black dots, right side) and vehicle (white dots). (B) Photomicrograph
ns in the MeA, which are indicated by arrows. IA – interaural, CeA – central nucleus
3. Results
3.1. Determination of microinjection sites
A diagrammatic representation showing microinjection sites in
the MeA  of the animals used in the study is presented in Fig. 1A.
A photomicrograph of a coronal brain section depicting bilateral
microinjection sites in the MeA  of one representative animal is
presented in Fig. 1B.
3.2. Effect of MeA pretreatment with the selective
˛1-adrenoceptor antagonist WB4101 on restraint-related
cardiovascular changesBilateral microinjection of WB4101 (10, 15 and 20 nmol/100 nL)
did not affect baseline BP and HR values when compared with
aCSF-treated animals (Tables 1 and 2). The pretreatment with
WB4101 signiﬁcantly reduced the restraint-evoked HR increase
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Table 1
Basal values of the mean arterial pressure (MAP), before and after the microinjection of different doses with WB4101 (selective 1-adrenoceptor antagonist) into the MeA
of  the rats.
WB4101 (nmol/100 nL) Before (MAP) ± SEM (mmHg) After (MAP) ± SEM (mmHg) t = n = (sample)
0 96 ± 4 94 ± 3 0.2683 8
10 101 ± 4 100 ± 6 0.01702 5
15  86 ± 1 88 ± 1 0.7759 5
20  91 ± 1 87 ± 2 1.262 7
Table 2
Basal values of the heart rate (HR), before and after the microinjection of different doses with WB4101 (selective 1-adrenoceptor antagonist) into the MeA of the rats.
WB4101 (nmol/100 nL) Before (HR) ± SEM (bpm) After (HR) ± SEM (bpm) t = n = (sample)
0 366 ± 8 358 ± 5 0.8270 8
10  330 ± 16 334 ± 8 0.2197 5
15  361 ± 13 370 ± 10 0.5522 5
20  370 ± 7 375 ± 5 0.5746 7
Fig. 2. Mean arterial pressure (MAP) and heart rate (HR) changes in response to the injection of increasing doses of RX821002 (left side) and WB4101 (right side) 10, 15
and  20 nmol/100 nL in rats. Dose zero: vehicle (aCSF-treated,). Dose–effect curves were generated by linear regression analysis. Data shown represent the means ± SEM of
the  variation of MAP  and HR during the 60 min  of acute restraint.
Fig. 3. Effects of different doses of (WB4101 – 10, 15 and 20 nmol, n = 5, 5, 7 per group, respectively) or vehicle (aCSF-treated, n = 8) on changes in mean arterial pressure
(MAP)  and heart rate (HR) of animals submitted to 60 min of restraint stress. The minute 10 indicates the beginning of the restraint period. Data shown represent the
means  ± SEM. P < 0.05, compared with vehicle group; ANOVA followed by Dunnett’s post hoc test.
158 E.A.T. Fortaleza et al. / Pharmacological Research 66 (2012) 154– 162
Fig. 4. Effects of different doses of (RX821002 – 10, 15 and 20 nmol, n = 6, 5, 6 per group, respectively) or vehicle (aCSF-treated, n = 8) on changes in mean arterial pressure
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rMAP)  and heart rate (HR) of animals submitted to 60 min  of restraint stress. T
eans ± SEM. P < 0.05, compared with vehicle group; ANOVA followed by Dunnett’
t doses of 15 and 20 nmol (HR, F3,21 = 4.267, P < 0.05) without a
igniﬁcant effect on the BP response, when compared with aCSF-
reated animals (MAP  F3,21 = 0.3792, P > 0.05). The dose of 10 nmol
id not evoke a difference in restraint-related MAP  or HR
ncreases when compared with aCSF-treated animals (P > 0.05). A
ose-dependent relation was evidenced by linear regression analy-
is with a signiﬁcant correlation between doses and the attenuation
n the HR increase during restraint (r2 = 0.35, df = 23, P < 0.05)
ithout a signiﬁcant effect on the BP response (r2 = 0.0003551,
f = 23, P > 0.05) (Fig. 2). Recordings showing the cardiovascular
esponse of a rat pretreated with aCSF or WB4101 (15 nmol/100 nL)
n the MeA  and submitted to acute restraint are presented in
igs. 3–5.
ig. 5. Recordings of mean arterial pressure (MAP), pulsatile arterial pressure (PAP) and
estraint period of 60 min  in a control rat and in a rat whose MeA  was treated with WB41nute 10 indicates the beginning of the restraint period. Data shown represent the
 hoc test.
3.3. Effect of MeA pretreatment with the selective
˛2-adrenoceptor antagonist RX821002 on restraint-related
cardiovascular changes
Bilateral microinjection of RX821002 (10, 15 and
20 nmol/100 nL) did not affect baseline BP and HR values when
compared with aCSF-treated animals (Tables 3 and 4). Pretreatment
with RX821002 signiﬁcantly enhanced the restraint-evoked HR
increase at doses of 15 and 20 nmol (HR, F3,21 = 4.287, P < 0.05)
without a signiﬁcant effect on the BP response, when com-
pared with aCSF-treated animals (MAP  F3,21 = 0.2910, P > 0.05).
The dose of 10 nmol did not evoke changes in restraint-related
MAP  or HR increases when compared with aCSF-treated
 heart rate (HR) showing the cardiovascular changes observed before and during a
01 – 15 nmol/100 nL before restraint. The onset of restraint was at t = 10 min.
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Table 3
Basal values of the mean arterial pressure (MAP), before and after the microinjection of different doses with RX821002 (selective 2-adrenoceptor antagonist) into the MeA
of  the rats.
RX821002 (nmol/100 nL) Before (MAP) ± SEM (mmHg) After (MAP) ± SEM (mmHg) t = n = (sample)
0 96 ± 4 94 ± 3 0.2683 8
10 104  ± 3 101 ± 4 0.4893 6
15  93 ± 3 92 ± 5 0.1785 5
20  87 ± 4 90 ± 5 0.5337 6
Table 4
Basal values of the heart rate (HR), before and after the microinjection of different doses with RX821002 (selective 2-adrenoceptor antagonist) into the MeA  of the rats.
RX821002 (nmol/100 nL) Before (HR) ± SEM (bpm) After (HR) ± SEM (bpm) t = n = (sample)
0 366 ± 8 358 ± 5 0.8270 8
10 356 ±  7 355 ± 8 0.1257 6
15 351 ±  8 363 ± 11 0.8194 5
20  355 ± 9 367 ± 7 0.9843 6
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tig. 6. Recordings of mean arterial pressure (MAP), pulsatile arterial pressure (PAP
estraint period of 60 min  in a control rat and in a rat whose MeA  was treated with
nimals (P > 0.05). A dose dependency was evidenced by lin-
ar regression analysis that showed a signiﬁcant correlation
etween doses and enhancement in the HR increase (r2 = 0.3703,
f = 23, P < 0.05) without a signiﬁcant effect on the BP response
r2 = 0.001064, df = 23, P > 0.05) (Fig. 2). Recordings showing the
ardiovascular response of a rat pretreated with aCSF or RX821002
15 nmol/100 nL) in the MeA  and submitted to acute restraint are
resented in Fig. 6.
. Discussion
To study the possible involvement of noradrenergic neuro-
ransmission in the MeA  in the modulation of restraint-evoked
ardiovascular responses, we pretreated this area with different
oses of selective -adrenoceptor antagonists. Bilateral microin-
ection of WB4101, a selective 1-adrenoceptor antagonist, into
he MeA  caused a signiﬁcant reduction in tachycardia evoked by
cute restraint. The effect of WB4101 on the restraint-evoked HR
esponse was dose-dependent. Pretreatment with WB4101 had no
igniﬁcant effect on the restraint-evoked pressor response. In con-
rast, pretreatment with RX821002, a selective 2-adrenoceptor heart rate (HR) showing the cardiovascular changes observed before and during a
002 – 15 nmol/100 nL before restraint. The onset of restraint was at t = 10 min.
antagonist, signiﬁcantly increased the restraint-evoked tachy-
cardiac response, in a dose-related manner. Pretreatment with
RX821002 did not affect the restraint-evoked pressor response.
The drugs used in our study did not affect baseline BP or HR,
thus indicating that the MeA  does not contribute to cardiovascular
control at rest. These results corroborate previous data from the
literature indicating no changes in cardiovascular responses after
microinjection of these antagonists into the MeA  or other brain
structures [4,19].
Restraint is an inescapable stressful stimulus that causes car-
diovascular changes that are characterized by both BP and HR
increases [7,19,41,48–50].  The idea of a MeA  involvement in the
mediation of stress-evoked responses is reinforced by data from
the literature showing that its electrical stimulation activates the
hypothalamic–pituitary–adrenal HPA axis in anesthetized rats [51].
Moreover, the MeA  is connected with hypothalamic and brainstem
areas that are involved in cardiovascular regulation [8–10].Structures such as the lateral septal area [20,52],  lateral
hypothalamus [53,54],  medial prefrontal cortex [7],  bed nucleus
of stria terminalis [3],  MeA  and central amygdala (CeA) [4,19,50]
and the paraventricular nucleus of the hypothalamus (PVN) [56,57]
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ere proposed to be part of the circuitry that modulates restraint-
voked cardiovascular responses. Data from the literature also
ndicate a larger activation of the MeA, among other amygaloid
uclei, during stressful situations, as is indicated by the large
xpression of c-fos protein in this area after exposure to aversive
ituations [19,48,58–64].
Inhibition of the MeA  with muscimol attenuated the restraint-
voked pressor response [19]. In addition, in a previous study from
ur group, it was  shown that bilateral microinjection of the non-
elective synaptic blocker CoCl2 into the MeA  increased the HR
esponse to acute restraint, without a signiﬁcant effect on the BP
esponse [4]). Together, these data suggest that the MeA  is involved
n the modulation of cardiovascular responses evoked by acute
estraint.
Besides activating the HPA axis and the sympathetic nervous
ystem, exposure to stress also induces a noradrenaline (NA)
elease, which facilitates synaptic transmission in many of the brain
egions involved in modulation of stress-related behavioral and
hysiological responses [65–67].  The NA may  affect HPA reactiv-
ty not only by acting directly on the PVN [68–70],  but also through
ctions in extrahypothalamic regions that exert a modulatory input
n the HPA axis. For example, it has been shown that noradrenergic
eurotransmission is activated in the MeA  under acute immobiliza-
ion stress, and that the NA released in MeA  during stress facilitates
he activation of the HPA axis [1].  The idea that the MeA  participates
n the extra hypothalamic circuitry facilitating the stress-induced
PA activation is consistent with previous reports showing that a
irect stimulation of MeA  increased corticosterone levels [51,71].
Studies on the expression of mRNA and receptor binding evi-
enced the presence of noradrenergic receptors in the MeA  [27,28],
hus suggesting the existence of a noradrenergic system in this
rea. The selective blockade of 1-adrenoceptors by the microin-
ection of WB4101 (10, 15 and 20 nmol) into the MeA  reduced,
n a dose-dependent manner, the restraint-evoked HR response,
ithout affecting the BP response. This result suggests that local
1-adrenoceptors play a facilitatory role on the restraint-evoked
achycardiac response in the rat. These data are different from those
esulting from experiments performed with the administration of
oCl2 into the MeA, in which there was an increased tachycardiac
estraint-evoked response [4].  However, it is important to point
ut that CoCl2 inhibits all synaptic neurotransmissions in the area.
elective antagonists such as WB4101 and RX821002 have been
reviously used to identify the subtype of -adrenoceptor that is
nvolved in the mediation of restraint-evoked pressor and tachy-
ardiac responses when microinjected into the BST [3].  The present
esults indicate that local 1-adrenoceptors in the MeA  play an
nhibitory role in the HR increase evoked by restraint stress.
The selective blockade of 2-adrenoceptors by the microin-
ection of RX821002 (10, 15 and 20 nmol) into the MeA  caused
ose-dependent increases in the restraint-evoked tachycardiac
esponse, similarly to that observed after the pharmacological abla-
ion of the area with CoCl2.
2-Adrenoceptors are located both pre- and post-synaptically
n the brain and are found in high density in the MeA  [72,73]. The
ctivation of 2-adrenoceptors results in the inhibition of neuronal
ring and a decrease in NA release. Also, it is well known that selec-
ive 2-adrenoceptor antagonists such as the RX821002, can either
acilitate or potentiate the noradrenaline release in rats under basal
onditions or during exposure to stress [74–80].  This can lead to
ncreased levels of noradrenaline in rat brain areas such as the MeA
81–84]. Our results suggest that 2-adrenoceptors in the MeA  play
n inhibitory inﬂuence on restraint-evoked tachycardiac responses
n the rat.
2-Adrenergic binding sites have been detected in the MeA
72,73]. Moreover, previous data indicate that the cardiovascu-
ar response evoked by NA microinjection into the MeA  involvesl Research 66 (2012) 154– 162
local 2-adrenoceptors [35], thus suggesting that in the MeA  these
receptors are involved with cardiovascular modulation.
The present results show that 1- and 2-adrenoceptors in the
MeA  play different roles in the modulation of the cardiac response
to acute restraint. Cardiac autonomic control is a result of a bal-
ance between parasympathetic and sympathetic activities [85].
Parasympathetic stimulation depresses HR and cardiac contrac-
tile force, whereas sympathetic activation increases it. However,
simultaneous activation of both autonomic systems is associated
with chemoreceptor, startle, noxious and defensive responses [86].
Stress-related cardiac and pressor responses are sympathetically
mediated, because both are abolished after ganglion blockade and
are respectively blocked by pretreatment with either  or -
adrenergic antagonists [87,88].  Moreover, previous results from
the literature indicated that treatment with a parasympathetic
blocker increased the tachycardiac response evoked by a psycho-
logical stress [3,7,89,90],  thus suggesting a simultaneous activation
of the cardiac parasympathetic and the sympathetic systems dur-
ing psychological stress. An emotional–autonomic pathway has
been localized in the extended amygdaloid complex of the rat.
Microinjection of pseudorabies virus into the adrenal gland, stellate
ganglion which regulates the heart, or celiac ganglion which inner-
vates the gastrointestinal tract caused extensive transneuronal
labeling in limbic system areas such as the extended amygdaloid
complex, lateral septum, and infralimbic, insular, and ventrome-
dial temporal cortical regions [91], suggesting that these areas are
linked by multisynaptic connections to the sympathetic outﬂows.
Tachycardia evoked by restraint stress in rats is well doc-
umented [41,48,92].  There is evidence suggesting that the
amygdaloid complex may  be a part of the brain circuitry involved
in this elevated cardiac sympathetic drive. Both electrical and
chemical stimulation of the amygdala evoked heart rate increases
[11,93–95],  thus suggesting the involvement of this area in the
modulation of cardiac responses.
5. Conclusion
In summary, we  propose that in the rat, 1-adrenoceptors
in the MeA  play a facilitatory role in the cardiac component
of the restraint-evoked cardiovascular response whereas 2-
adrenoceptors have an inhibitory role in the modulation of the
cardiac component of the response.
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